longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Metagenomi Therapeutics

MGX

1.1002.65% ( -0.030 )
Closed: Sep 18, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Metagenomi director Laurence Reid acquires common shares worth $23,403.95

    PUBT·Sep 11 at 11:52 PM
    MGX-2.65%
  • Metagenomi CEO to join Wells Fargo Healthcare Conference fireside chat

    PUBT·Sep 1 at 12:03 PM
    WFC-0.89%MGX-2.65%
  • J.P. Morgan Keeps Their Hold Rating on Metagenomi, Inc. (MGX)

    Tip Ranks·Aug 18 at 04:15 AM
    MGX-2.65%
  • Metagenomi targets 2027 clinical trial start for hemophilia A genome-editing candidate MGX-001

    PUBT·Aug 10 at 08:25 PM
    MGX-2.65%
  • AI | MGX Raises $49 Billion Fund for Artificial Intelligence Deals

    CoinLive·Jul 2 at 06:31 AM
    MGX-2.65%
  • Metagenomi Announces Board Changes and Shareholder Meeting Results

    Tip Ranks·Jun 10 at 10:51 AM
    MGX-2.65%
  • Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

    PR Newswire·Jun 5 at 07:45 PM
    MGX-2.65%